Alpha 2.0
Login Register
» Authors » Albert Fournier

Albert Fournier

Explore the profile of Albert Fournier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 702
Followers 0
Related Specialties
Nephrology
General Medicine
Cardiology & Vascular Diseases
Top 10 Co-Authors
Roxana Oprisiu
Gabriel Choukroun
Jean-Michel Achard
Irina Shahapuni
Jean Michel Achard
Hakim Mazouz
Claire Presne
Philippe Moriniere
Najeh El Esper
Olivier Godefroy
Published In
Nephrol Dial Transplant
Lancet
Kidney Int
Stroke
J Hypertens
Affiliations
Soon will be listed here.
Recent Articles
11.
About the association between high alkaline phosphatase and risk of death and hospitalization in dialysis patients
Baakrim A, Shahapuni I, Rouached M, Fournier A
Kidney Int . 2009 May; 75(10):1114. PMID: 19404286
No abstract available.
12.
Telmisartan for prevention of cardiovascular events
Fournier R, Achard J, Fournier A
N Engl J Med . 2009 Jan; 360(3):303. PMID: 19148964
No abstract available.
13.
Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors
Faure S, Bureau A, Oudart N, Javellaud J, Fournier A, Achard J
J Hypertens . 2008 Sep; 26(10):2008-15. PMID: 18806625
Objectives: The contribution of the AT2 and AT4 angiotensin receptors to the protective role of the AT1 receptor blocker candesartan in acute ischemic stroke was investigated. Methods: Embolic stroke was...
14.
Vitamin D levels and early mortality among incident hemodialysis patients
Mailliez S, Shahapuni I, Lecaque C, Massy Z, Choukroun G, Fournier A
Kidney Int . 2008 Jul; 74(3):389. PMID: 18626498
No abstract available.
15.
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease
Rouached M, El Kadiri Boutchich S, Al Rifai A, Garabedian M, Fournier A
Kidney Int . 2008 Jul; 74(3):389-90. PMID: 18626497
No abstract available.
16.
Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials
Segall L, Oprisiu R, Fournier A, Covic A
J Nephrol . 2008 Jul; 21(3):374-83. PMID: 18587726
Background: Stroke is the leading cause of serious long-term disability and the third leading cause of death in the Western world. In patients with chronic kidney disease (CKD), stroke and...
17.
The JIKEI trial
Boutitie F, Gueyffier F, Achard J, Temmar M, Fournier A
Lancet . 2007 Dec; 370(9602):1825-6. PMID: 18061051
No abstract available.
18.
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis
Shahapuni I, Esper N, Opisiv R, Massy Z, Choukroun G, Garabedian M, et al.
Nephrol Dial Transplant . 2007 Nov; 23(4):1456-7. PMID: 18039645
No abstract available.
19.
[Diuretic-based therapy]
Presne C, Monge M, Mansour J, Oprisiu R, Choukroun G, Achard J, et al.
Nephrol Ther . 2007 Oct; 3(6):392-426. PMID: 17919642
Diuretics are pharmacological agents that increase natriuresis through inhibition of tubular re-absorption of sodium. The mechanisms and site of this inhibition differ with each drug class, accounting for their additive...
20.
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II
Boutitie F, Oprisiu R, Achard J, Mazouz H, Wang J, Messerli F, et al.
J Hypertens . 2007 Jul; 25(8):1543-53. PMID: 17620946
Background: Stroke prevention by antihypertensive therapy is believed to be related to the fall in blood pressure (BP). Experimental data have documented that activation of non-AT1 receptors of angiotensin II...